Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

<h4>Background</h4> <p>We identified anti-obesity medications withdrawn since 1950 because of adverse drug reactions after regulatory approval, and examined the evidence used to support such withdrawals, investigated the mechanisms of the adverse reactions, and explored the trends...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Onakpoya, I, Heneghan, C, Aronson, J
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	BioMed Central 2016

Παρόμοια τεκμήρια

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2017)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
ανά: Onakpoya, IJ, κ.ά.
Έκδοση: (2016)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2016)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
ανά: Igho J. Onakpoya, κ.ά.
Έκδοση: (2019-03-01)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2017)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
ανά: Onakpoya, I
Έκδοση: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2017)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
ανά: Daniele Sartori, κ.ά.
Έκδοση: (2020-08-01)

Pharmacogenetics and adverse drug reactions
ανά: Ferner, R, κ.ά.
Έκδοση: (2010)

An agenda for research on adverse drug reactions.
ανά: Aronson, J
Έκδοση: (2007)

Adverse drug reactions--no farewell to harms.
ανά: Aronson, J
Έκδοση: (2007)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
ανά: Aronson, J
Έκδοση: (2008)

Adverse drug reactions: definitions, diagnosis, and management.
ανά: Edwards, I, κ.ά.
Έκδοση: (2000)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
ανά: Aronson, J
Έκδοση: (2017)

Adverse drug reactions: keeping up to date.
ανά: Aronson, J, κ.ά.
Έκδοση: (2002)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
ανά: Aronson, J
Έκδοση: (2013)

Paradoxical reactions: Under-recognized adverse effects of drugs?
ανά: Hauben, M, κ.ά.
Έκδοση: (2006)

National differences in publishing papers on adverse drug reactions.
ανά: Ferner, R, κ.ά.
Έκδοση: (2005)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
ανά: Onakpoya, IJ, κ.ά.
Έκδοση: (2020)

Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions /
ανά: Aronson, Jeffrey K.
Έκδοση: (2006)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2018)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
ανά: Aronson, J
Έκδοση: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
ανά: Talbot, J, κ.ά.
Έκδοση: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
ανά: Talbot, J, κ.ά.
Έκδοση: (2012)

The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
ανά: Łukasz Dobrek
Έκδοση: (2022-08-01)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs
ανά: James D. Noyes, κ.ά.
Έκδοση: (2021-08-01)

Joining the DoTS: new approach to classifying adverse drug reactions.
ανά: Aronson, J, κ.ά.
Έκδοση: (2003)

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
ανά: Smith, C, κ.ά.
Έκδοση: (1996)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
ανά: Aronson, J
Έκδοση: (2005)

Lorcaserin in obesity: minimal benefits and ill-defined harms
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2019)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
ανά: Loke, Y, κ.ά.
Έκδοση: (2006)

Pharmacogenomics of cutaneous adverse drug reactions as implication for precision medicine
ανά: Chun-Bing Chen
Έκδοση: (2023-01-01)

Individualized medicine: Sex, hormones, genetics, and adverse drug reactions
ανά: Ann M. Moyer, κ.ά.
Έκδοση: (2019-12-01)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
ανά: Aronson, J, κ.ά.
Έκδοση: (2010)

Stephens' detection and evaluation of adverse drug reactions : principles and practice /
ανά: Talbot, J. C. C., κ.ά.
Έκδοση: (2012)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
ανά: McDowell, SE, κ.ά.
Έκδοση: (2013)

GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis
ανά: Ziqi Zhang, κ.ά.
Έκδοση: (2023-07-01)

Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports
ανά: Ruoqi Liu, κ.ά.
Έκδοση: (2019-12-01)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
ανά: Derry, S, κ.ά.
Έκδοση: (2001)

Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials
ανά: Derry, S, κ.ά.
Έκδοση: (2001)